The biopharmaceutical company Nektar (symbol NKTR) has finished was appears to be a well-formed bullish base.
NKTR has had a terrible time of it for years, but maybe it’s finally ready to turn around.
Sweet Nektar?
The biopharmaceutical company Nektar (symbol NKTR) has finished was appears to be a well-formed bullish base.
NKTR has had a terrible time of it for years, but maybe it’s finally ready to turn around.
